Nutrition and gas exchange The placenta intermediates the transfer of nutrients between mother and fetus. The perfusion of the intervillous spaces of the placenta with maternal blood allows the transfer of nutrients and oxygen from the mother to the fetus and the transfer of waste products and
carbon dioxide back from the fetus to the maternal blood. Nutrient transfer to the fetus can occur via both
active and
passive transport. Placental nutrient metabolism was found to play a key role in limiting the transfer of some nutrients. Adverse pregnancy situations, such as those involving maternal
diabetes or
obesity, can increase or decrease levels of nutrient transporters in the placenta potentially resulting in overgrowth or restricted growth of the fetus.
Excretion Waste products excreted from the fetus such as
urea,
uric acid, and
creatinine are transferred to the maternal blood by
diffusion across the placenta.
Immunity The placenta functions as a selective barrier between maternal and fetal cells, preventing maternal blood, proteins and
microbes (including
bacteria and most
viruses) from crossing the maternal-fetal barrier. A very small number of viruses including
rubella virus,
Zika virus and
cytomegalovirus (CMV) can travel across the placental barrier, generally taking advantage of conditions at certain gestational periods as the placenta develops. CMV and Zika travel from the maternal bloodstream via placental cells to the fetal bloodstream. Beginning as early as 13 weeks of gestation, and increasing linearly, with the largest transfer occurring in the third trimester,
IgG antibodies can pass through the human placenta, providing protection to the fetus
in utero. This passive immunity lingers for several months after birth, providing the newborn with a exact copy of the mother's long-term
humoral immunity to see the infant through the crucial first months of extrauterine life.
IgM antibodies, because of their larger size, cannot cross the placenta, one reason why infections acquired during pregnancy can be particularly hazardous for the fetus.
Hormonal regulation • The first hormone released by the placenta is called the
human chorionic gonadotropin (hCG) hormone. This is responsible for stopping the process at the end of menses when the
corpus luteum ceases activity and atrophies. If hCG did not interrupt this process, it would lead to spontaneous abortion of the fetus. The corpus luteum also produces and releases
progesterone and
estrogen, and hCG stimulates it to increase the amount that it releases. hCG is the indicator of pregnancy that
pregnancy tests look for. These tests will work when menses has not occurred or after implantation has happened on days seven to ten. hCG may also have an anti-antibody effect, protecting it from being rejected by the mother's body. hCG also assists the male fetus by stimulating the testes to produce testosterone, which is the hormone needed to allow the sex organs of the male to grow. •
Progesterone helps the
embryo implant by assisting passage through the fallopian tubes. It also affects the
fallopian tubes and the
uterus by stimulating an increase in secretions necessary for fetal nutrition. Progesterone, like hCG, is necessary to prevent spontaneous abortion because it prevents contractions of the uterus and is necessary for implantation. •
Estrogen is a crucial hormone in the process of proliferation. This involves the enlargement of the breasts and uterus, allowing for growth of the fetus and production of milk. Estrogen is also responsible for increased blood supply towards the end of pregnancy through
vasodilation. The levels of estrogen during pregnancy can increase so that they are thirty times what a non-pregnant woman mid-cycles estrogen level would be. •
Human placental lactogen (hPL) is a hormone used in pregnancy to develop fetal metabolism and general growth and development. Human placental lactogen works with
growth hormone to stimulate
insulin-like growth factor production and regulating intermediary metabolism. In the fetus, hPL acts on lactogenic receptors to modulate embryonic development, metabolism and stimulate production of IGF,
insulin, surfactant and
adrenocortical hormones. hPL values increase with multiple pregnancies, intact molar pregnancy,
diabetes and
Rh incompatibility. They are decreased with
toxemia,
choriocarcinoma, and
Placental insufficiency.
Immunological barrier The placenta and fetus may be regarded as a
foreign body inside the mother and must be protected from the normal
immune response of the mother that would cause it to be
rejected. The placenta and fetus are thus treated as sites of
immune privilege, with
immune tolerance. For this purpose, the placenta uses several mechanisms : • It secretes
neurokinin B-containing
phosphocholine molecules. This is the same mechanism used by
parasitic nematodes to avoid detection by the immune system of their
host. • There is presence of small lymphocytic suppressor cells in the fetus that inhibit maternal
cytotoxic T cells by inhibiting the response to
interleukin 2. However, the placental barrier is not the sole means of evading the immune system, as foreign fetal cells also persist in the maternal circulation, on the other side of the placental barrier.
DNA methylation The
trophoblast is the outer layer of cells of the
blastocyst (see day 9 in Figure, above, showing the initial stages of human embryogenesis). Placental trophoblast cells have a unique genome-wide
DNA methylation pattern determined by de novo
methyltransferases during
embryogenesis. This methylation pattern is principally required to regulate placental development and function, which in turn is critical for embryo survival. ==Clinical significance==